370 related articles for article (PubMed ID: 29125627)
1. Placental development and function in women with a history of placenta-related complications: a systematic review.
Reijnders IF; Mulders AGMGJ; Koster MPH
Acta Obstet Gynecol Scand; 2018 Mar; 97(3):248-257. PubMed ID: 29125627
[TBL] [Abstract][Full Text] [Related]
2. A placenta clinic approach to the diagnosis and management of fetal growth restriction.
Kingdom JC; Audette MC; Hobson SR; Windrim RC; Morgen E
Am J Obstet Gynecol; 2018 Feb; 218(2S):S803-S817. PubMed ID: 29254754
[TBL] [Abstract][Full Text] [Related]
3. Preeclampsia and intrauterine growth restriction: placental disorders still not fully understood.
Maršál K
J Perinat Med; 2017 Oct; 45(7):775-777. PubMed ID: 28985185
[No Abstract] [Full Text] [Related]
4. Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.
Walker MG; Hindmarsh PC; Geary M; Kingdom JCP
J Obstet Gynaecol Can; 2010 Dec; 32(12):1134-1139. PubMed ID: 21176324
[TBL] [Abstract][Full Text] [Related]
5. Elevated Circulating and Placental SPINT2 Is Associated with Placental Dysfunction.
Murphy CN; Walker SP; MacDonald TM; Keenan E; Hannan NJ; Wlodek ME; Myers J; Briffa JF; Romano T; Roddy Mitchell A; Whigham CA; Cannon P; Nguyen TV; Kandel M; Pritchard N; Tong S; Kaitu'u-Lino TJ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299087
[TBL] [Abstract][Full Text] [Related]
6. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity.
Austdal M; Silva GB; Bowe S; Thomsen LCV; Tangerås LH; Bjørge L; Bathen TF; Iversen AC
Hypertension; 2019 Nov; 74(5):1136-1143. PubMed ID: 31495279
[TBL] [Abstract][Full Text] [Related]
8. Indications for delivery in pre-eclampsia.
Varnier N; Brown MA; Reynolds M; Pettit F; Davis G; Mangos G; Henry A
Pregnancy Hypertens; 2018 Jan; 11():12-17. PubMed ID: 29523266
[TBL] [Abstract][Full Text] [Related]
9. Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction.
Pecks U; Rath W; Caspers R; Sosnowsky K; Ziems B; Thiesen HJ; Maass N; Huppertz B
Placenta; 2013 Dec; 34(12):1142-9. PubMed ID: 24404588
[TBL] [Abstract][Full Text] [Related]
10. Involvement of oxidative stress in placental dysfunction, the pathophysiology of fetal death and pregnancy disorders.
Sultana Z; Qiao Y; Maiti K; Smith R
Reproduction; 2023 Aug; 166(2):R25-R38. PubMed ID: 37318094
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes.
Cain MA; Salemi JL; Tanner JP; Kirby RS; Salihu HM; Louis JM
Am J Obstet Gynecol; 2016 Oct; 215(4):484.e1-484.e14. PubMed ID: 27263996
[TBL] [Abstract][Full Text] [Related]
12. Clinicoplacental phenotypes vary with gestational age: an analysis by classical and clustering methods.
Stanek J; Biesiada J; Trzeszcz M
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):392-8. PubMed ID: 24506140
[TBL] [Abstract][Full Text] [Related]
13. Placental dysfunction and fetal programming: the importance of placental size, shape, histopathology, and molecular composition.
Longtine MS; Nelson DM
Semin Reprod Med; 2011 May; 29(3):187-96. PubMed ID: 21710395
[TBL] [Abstract][Full Text] [Related]
14. Prediction and prevention of ischemic placental disease.
Friedman AM; Cleary KL
Semin Perinatol; 2014 Apr; 38(3):177-82. PubMed ID: 24836830
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
[TBL] [Abstract][Full Text] [Related]
16. Placental ABCA1 and ABCG1 expression in gestational disease: Pre-eclampsia affects ABCA1 levels in syncytiotrophoblasts.
Baumann M; Körner M; Huang X; Wenger F; Surbek D; Albrecht C
Placenta; 2013 Nov; 34(11):1079-86. PubMed ID: 23880356
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration.
Herraiz I; Simón E; Gómez-Arriaga PI; Martínez-Moratalla JM; García-Burguillo A; Jiménez EA; Galindo A
Int J Mol Sci; 2015 Aug; 16(8):19009-26. PubMed ID: 26287164
[TBL] [Abstract][Full Text] [Related]
18. Effect of placental laterality on uterine artery resistance and development of preeclampsia and intrauterine growth retardation.
Kofinas AD; Penry M; Swain M; Hatjis CG
Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1536-9. PubMed ID: 2603907
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for placental senescence in the genesis of obstetric complications and fetal growth restriction?
Sultana Z; Maiti K; Dedman L; Smith R
Am J Obstet Gynecol; 2018 Feb; 218(2S):S762-S773. PubMed ID: 29275823
[TBL] [Abstract][Full Text] [Related]
20. Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without pre-eclampsia.
Madazli R; Benian A; Ilvan S; Calay Z
J Obstet Gynaecol; 2006 Jan; 26(1):5-10. PubMed ID: 16390700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
